Prelude Therapeutics furnishes May 2023 investor presentation

Prelude Therapeutics Inc

Company prepared investor presentation materials for use in investor meetings.
Presentation provided as Exhibit 99.1, furnished under Regulation FD, not filed.
No specific financial or pipeline updates disclosed in the 8-K filing body.

item 7.01 item 9.01

Prelude Therapeutics Inc filing history →

Source: SEC EDGAR

accession 0000950170-23-025712

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.